Page 10 - Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma

CUAJ – Consensus Statement Mason et al
KCRNC consensus: Cytoreductive nephrectomy for mRCC

References

1. Mickisch GH, Garin A, van Poppel H, de Prijck L, Sylvester R. Radical
nephrectomy plus interferon-alfa-based immunotherapy compared with interferon
alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet.
2001;358:966-70.
2. Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC, et
al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b
alone for metastatic renal-cell cancer. The New England journal of medicine.
2001;345:1655-9.
3. Mejean A, Ravaud A, Thezenas S, Colas S, Beauval JB, Bensalah K, et al.
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma. N
Engl J Med. 2018.
4. Bex A, Mulders P, Jewett MA et al. Immediate Surgery or Surgery After
Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer. European
Society of Medical Oncology annual congress. 2017.
5. Motzer RJ, Tannir NM, McDermott DF, Aren Frontera O, Melichar B, Choueiri
TK, et al. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell
Carcinoma. N Engl J Med. 2018;378:1277-90.
6. Macleod LC, Odisho AY, Tykodi SS, Holt SK, Harper JD, Gore JL. Comparative
Effectiveness of Initial Surgery vs Initial Systemic Therapy for Metastatic Kidney
Cancer in the Targeted Therapy Era: Analysis of a Population-based Cohort.
Urology. 2017;23:23.
7. Klatte T, Fife K, Welsh SJ, Sachdeva M, Armitage JN, Aho T, et al. Prognostic
effect of cytoreductive nephrectomy in synchronous metastatic renal cell
carcinoma: a comparative study using inverse probability of treatment weighting.
World J Urol. 2017;18:18.
8. Song Y, Du C-X, Zhang W, Sun Y-K, Yang L, Cui C-X, et al. Impact of
Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell
Carcinoma Treated by Targeted Therapy. Chin Med J. 2016;129:530-5.
9. Hanna N, Sun M, Meyer CP, Nguyen PL, Pal SK, Chang SL, et al. Survival
Analyses of Patients With Metastatic Renal Cancer Treated With Targeted
Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data
Base Study. J Clin Oncol. 2016;34:3267-75.
10. de Groot S, Redekop WK, Sleijfer S, Oosterwijk E, Bex A, Kiemeney LALM, et
al. Survival in Patients With Primary Metastatic Renal Cell Carcinoma Treated
With Sunitinib With or Without Previous Cytoreductive Nephrectomy: Results
From a Population-based Registry. Urology. 2016;95:121-7.